Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors

被引:0
|
作者
Muratori, Francesco [1 ]
Foschi, Lorenzo [1 ]
Roselli, Giuliana [2 ]
Frenos, Filippo [1 ]
Tamburini, Angela [3 ]
Palomba, Annarita [4 ]
Greto, Daniela [5 ]
Loi, Mauro [5 ]
Beltrami, Giovanni [6 ]
Capanna, Rodolfo [7 ]
Mondanelli, Nicola [8 ]
Campanacci, Domenico Andrea [1 ]
机构
[1] Azienda Osped Univ Careggi, Dept Orthopaed Oncol, Largo Palagi 1, Florence, Italy
[2] Azienda Osped Univ Careggi, Dept Radiol, Florence, Italy
[3] Azienda Osped Univ Meyer, Dept Paediat Oncoematol, Florence, Italy
[4] Azienda Osped Univ Careggi, Dept Pathol, Florence, Italy
[5] Azienda Osped Univ Careggi, Dept Radiotherapy, Florence, Italy
[6] Azienda Osped Univ Meyer, Dept Paediat Orthopaed, Florence, Italy
[7] Azienda Osped Univ Pisana, Orthopaed Clin, Pisa, Italy
[8] Azienda Osped Univ Senese, Orthopaed Clin, Siena, Italy
关键词
Ewing sarcoma; Bone tumor; Tumor volume; Age; Metastasis; ITALIAN SARCOMA GROUP; SINGLE INSTITUTION; BONE; CHEMOTHERAPY; ADJUVANT; SURVIVAL; EXPERIENCE; THERAPY; SURGERY; RADIATION;
D O I
10.1007/s00590-021-03077-y
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose Authors retrospectively analyzed possible prognostic factors in a series of patients affected by Ewing sarcoma of extremities (eEWS) and treated over a 20-year period at a single institution. Methods Between 1997 and 2017, 88 bone eEWS were treated at our institution. Staging, age, gender, tumoral volume, local treatment, surgical margins, post-ChT necrosis were investigated for prognostic correlation with overall survival (OS) and event-free survival (EFS). Median follow-up was 74 months (1-236). Results Staging of disease correlated with OS (81% vs 59%, p = 0.01) and not with EFS (68% vs 57%, p = 0.28) in localized vs metastatic eEWS at presentation. Age >= 14 years (p = 0.002) and volume >= 100 cm3 (p = 0.04) were significant negative prognostic factors. No difference was found in local treatment: OS was 76% vs 63% (p = 0.33), while EFS was 68% vs 49% (p = 0.06) after surgery alone or surgery + radiotherapy, respectively. Regarding surgical margins, OS was 76% vs 38% (p = 0.14), and EFS was 65% vs 33% (p = 0.14) in adequate vs not adequate, respectively. OS was 86% and 68% in good and poor responders, respectively (p = 0.13). Conclusion In eEWS, metastatic disease at presentation, age > 14 years and tumoral volume > 100 cm(3) are negative prognostic factors. Intensified adjuvant ChT can improve prognosis in poor responders and metastatic patients.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [21] Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors - Local outcome and prognostic factors
    Krasin, MJ
    Davidoff, AM
    Rodriguez-Galindo, C
    Billups, CA
    Fuller, CE
    Neel, MD
    Merchant, TE
    CANCER, 2005, 104 (02) : 367 - 373
  • [22] Local and Systemic Control of Ewing's Bone Sarcoma Family Tumors of the Ribs
    Briccoli, Antonio
    Rocca, Michele
    Salone, Mariacristina
    Palmerini, Emanuela
    Balladelli, Alba
    Ferrari, Cristina
    Di Fiore, Maria
    Bacci, Gaetano
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 222 - 226
  • [23] Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol
    Lopez Guerra, Jose Luis
    Marquez-Vega, Catalina
    Lucia Ramirez-Villar, Gema
    Cabrera, Patricia
    Ordonez, Rafael
    Manuel Praena-Fernandez, Juan
    Jose Ortiz, Maria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (04) : 294 - 301
  • [24] Analysis of prognostic factors in ewing sarcoma family of tumors -: Review of St. Jude Children's Rresearch Hospital studies
    Rodriguez-Galindo, Carlos
    Liu, Tiebin
    Krasin, Matthew J.
    Wu, Jianrong
    Billups, Catherine A.
    Daw, Najat C.
    Spunt, Sheri L.
    Rao, Bhaskar N.
    Santana, Victor M.
    Navid, Fariba
    CANCER, 2007, 110 (02) : 375 - 384
  • [25] Evaluation of Outcome and Prognostic Factors in Extraosseous Ewing Sarcoma
    Biswas, Bivas
    Shukla, N. K.
    Deo, S. V. S.
    Agarwala, Sandeep
    Sharma, D. N.
    Vishnubhatla, Sreenivas
    Bakhshi, Sameer
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 1925 - 1931
  • [26] Prognostic factors in primary nonmetastatic Ewing sarcoma of the rib in children and young adults
    Qureshi, Sajid S.
    Kembhavi, Seema
    Vora, Tushar
    Ramadwar, Mukta
    Laskar, Siddharth
    Talole, Sanjay
    Kurkure, Purna
    JOURNAL OF PEDIATRIC SURGERY, 2013, 48 (04) : 764 - 770
  • [27] Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center
    Wan, Wei
    Lou, Yan
    Hu, Zhiqi
    Wang, Ting
    Li, Jinsong
    Tang, Yu
    Wu, Zhipeng
    Xu, Leqin
    Yang, Xinghai
    Song, Dianwen
    Xiao, Jianru
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (02) : 313 - 320
  • [28] Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience
    W. Shannon Orr
    Jason W. Denbo
    Catherine A. Billups
    Jianrong Wu
    Fariba Navid
    Bhaskar N. Rao
    Andrew M. Davidoff
    Matthew J. Krasin
    Annals of Surgical Oncology, 2012, 19 : 3816 - 3822
  • [29] Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children's Research Hospital Experience
    Orr, W. Shannon
    Denbo, Jason W.
    Billups, Catherine A.
    Wu, Jianrong
    Navid, Fariba
    Rao, Bhaskar N.
    Davidoff, Andrew M.
    Krasin, Matthew J.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (12) : 3816 - 3822
  • [30] Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology
    Erkan Arpaci
    Tarkan Yetisyigit
    Metin Seker
    Dogan Uncu
    Ummugul Uyeturk
    Berna Oksuzoglu
    Umut Demirci
    Ugur Coskun
    Mehmet Kucukoner
    Abdurrahman Isıkdogan
    Mevlude Inanc
    Necati Alkis
    Metin Ozkan
    Medical Oncology, 2013, 30